Related Experiment Video
Updated: May 27, 2025
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.4K
Bullous pemphigoid
Hossein Akbarialiabad1,2, Enno Schmidt3, Aikaterini Patsatsi4
1Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Nature Reviews. Disease Primers
|February 20, 2025
Summary
Bullous pemphigoid is an autoimmune blistering disease affecting older adults, caused by antibodies to skin adhesion proteins. Management involves corticosteroids, immunosuppressants, and biologics, with ongoing research for better treatments.
Area of Science:
- Dermatology
- Immunology
- Autoimmune Diseases
Background:
- Bullous pemphigoid is a chronic autoimmune blistering disease affecting the elderly.
- It involves autoantibodies targeting hemidesmosomal proteins BP180 and BP230, crucial for skin adhesion.
- Increasing incidence is linked to an aging population and better diagnostics.
Purpose of the Study:
- To provide a comprehensive overview of bullous pemphigoid.
- To discuss its pathogenesis, diagnosis, and current treatment strategies.
- To highlight challenges in management and future research directions.
Main Methods:
- Review of clinical presentation and histopathology.
- Analysis of direct immunofluorescence and serological diagnostic tests.
- Evaluation of treatment outcomes with corticosteroids, immunosuppressants, and biologics (rituximab, omalizumab).
Main Results:
- Bullous pemphigoid is characterized by tense blisters and is increasing in incidence.
- Diagnosis relies on a combination of clinical, histological, and immunological findings.
- Current treatments include corticosteroids, immunosuppressive agents, and biologics, with ongoing research for novel therapies.
Conclusions:
- Bullous pemphigoid management requires addressing symptom control and preventing blister formation.
- Long-term care, particularly in elderly patients with comorbidities, presents significant challenges.
- Further research into molecular mechanisms and therapeutic targets is essential for developing safer and more effective treatments.
Related Concept Videos
01:30Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
342
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
342
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
114
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
114
01:23Skin Diseases and Disorders
2.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K
01:30Peptic Ulcer Disease I: Introduction
118
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
118
01:28Peptic Ulcer Disease II: Pathophysiology
218
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
218